Unexpected decline in tuberculosis cases coincident with economic recession - United States, 2009

Abstract

BackgroundSince 1953, through the cooperation of state and local health departments, the U.S. Centers for Disease Control and Prevention (CDC) has collected information on incident cases of tuberculosis (TB) disease in the United States. In 2009, TB case rates declined -11.4%, compared to an average annual -3.8% decline since 2000. The unexpectedly large decline raised concerns that TB cases may have gone unreported. To address the unexpected decline, we examined trends from multiple sources on TB treatment initiation, medication sales, and laboratory and genotyping data on culture-positive TB.MethodsWe analyzed 142,174 incident TB cases reported to the U. S. National Tuberculosis Surveillance System (NTSS) during January 1, 2000-December 31, 2009; TB control program data from 59 public health reporting areas; self-reported data from 50 CDC-funded public health laboratories; monthly electronic prescription claims for new TB therapy prescriptions; and complete genotyping results available for NTSS cases. Accounting for prior trends using regression and time-series analyses, we calculated the deviation between observed and expected TB cases in 2009 according to patient and clinical characteristics, and assessed at what point in time the deviation occurred.ResultsThe overall deviation in TB cases in 2009 was -7.9%, with -994 fewer cases reported than expected (P < .001). We ruled out evidence of surveillance underreporting since declines were seen in states that used new software for case reporting in 2009 as well as states that did not, and we found no cases unreported to CDC in our examination of over 5400 individual line-listed reports in 11 areas. TB cases decreased substantially among both foreign-born and U.S.-born persons. The unexpected decline began in late 2008 or early 2009, and may have begun to reverse in late 2009. The decline was greater in terms of case counts among foreign-born than U.S.-born persons; among the foreign-born, the declines were greatest in terms of percentage deviation from expected among persons who had been in the United States less than 2 years. Among U.S.-born persons, the declines in percentage deviation from expected were greatest among homeless persons and substance users. Independent information systems (NTSS, TB prescription claims, and public health laboratories) reported similar patterns of declines. Genotyping data did not suggest sudden decreases in recent transmission.ConclusionsOur assessments show that the decline in reported TB was not an artifact of changes in surveillance methods; rather, similar declines were found through multiple data sources. While the steady decline of TB cases before 2009 suggests ongoing improvement in TB control, we were not able to identify any substantial change in TB control activities or TB transmission that would account for the abrupt decline in 2009. It is possible that other multiple causes coincident with economic recession in the United States, including decreased immigration and delayed access to medical care, could be related to ...

A Review of Health Consequences of Recessions Internationally and a Synthesis of the US Response during the Great Recession

“…157 Studies of unemployment trends and deaths due to causes related to infections, particularly pneumonia and tuberculosis, find that greater unemployment is associated with decreases in deaths due to infectious disease. 12,17,37,39,158 A potential pathway put forth in a recent study suggests that less economic activity reduces the spread of communicable disease such as pneumonia or flu for workers through the essential quarantine of being unemployed and staying home. 159 However, the mechanistic pathway for why we see this relation in mortality for older populations is still unclear.…”

Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey

“…Whether the costs of drugs are perceived as affordable will depend for a large part on who is bearing the burden: the patient or the healthcare system. For the patient, out-of-pocket expenses and indirect costs are a strong driver of healthcare-seeking behaviour and adherence to treatment [2][3][4]; whereas, for the healthcare system, drug and service delivery costs are important considerations. The recent economic recession has shown that financial constraints on healthcare systems can have detrimental effects on the incidence of infectious disease [5,6].…”

Predicting U.S. Tuberculosis Case Counts through 2020

“…In addition, although the relationship between Human Immunodeficiency Virus (HIV) infection and TB is well described [32], we were not able to incorporate information on HIV status due to underreporting and lack of published HIV incidence and prevalence estimates in the United States by country of origin. We assumed current trends in TB cases will continue with cases declining in a linear pattern; however, trends can be affected by changes in behavior, policies, or other factors that influence population and immigration [20], [22]. Although the linear regression model was not a good fit for all countries, we showed that our prediction results were generally conservative in relation to more complex regression models.…”

“…Immigration, which is directly affected by national policies and socioeconomic factors [20], is an important consideration in the number of TB cases among foreign-born persons [21], [22]. Major changes in immigration patterns could alter our case count predictions.…”